Form 8-K - Current report:
SEC Accession No. 0001493152-26-031946
Filing Date
2026-07-02
Accepted
2026-07-02 17:00:37
Documents
11
Period of Report
2026-06-26
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 39582
  Complete submission text file 0001493152-26-031946.txt   206630

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE qcls-20260626.xsd EX-101.SCH 3032
3 XBRL LABEL FILE qcls-20260626_lab.xml EX-101.LAB 34239
4 XBRL PRESENTATION FILE qcls-20260626_pre.xml EX-101.PRE 22370
16 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3233
Mailing Address 1185 AVENUE OF THE AMERICAS SUITE 249 NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS SUITE 249 NEW YORK NY 10036 856-848-8698
Q/C TECHNOLOGIES, INC. (Filer) CIK: 0001321834 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36268 | Film No.: 261152705
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)